Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing

"Soter Bio was built to support advanced therapeutic programs that depend on reliable, rapid, scalable input materials," said Mike Stewart, Founder and CEO of Soter Bio. "Partnering with Cellipont ...

Akums Strengthens European and UK Presence -- India's Largest CDMO Expands Global Footprint

NEW DELHI , Feb. 23, 2026 /PRNewswire/ -- Akums Drugs & Pharmaceuticals Ltd., India's largest CDMO, has secured European Union Good Manufacturing Practice (EU GMP) certification for two of its ...
Morningstar

Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production

EXTON, Pa., Jan. 15, 2026 /PRNewswire/ -- Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new facility opened in May 2025 had ...
Morningstar

Locus Cell's Zhubei Smart GMP Facility Secures First International Phase III CDMO Manufacturing MOU with Cambium Bio

TAIPEI, Sept. 29, 2025 /PRNewswire/ -- Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium ...
Contract Pharma

Akums Secures EU GMP Certification for Two Manufacturing Facilities in India

Akums Drugs & Pharmaceuticals Ltd., India's largest CDMO, has secured European Union Good Manufacturing Practice ...
Nasdaq

Polyrizon Partners with Eurofins CDMO for Clinical Trial Material Production of PL-14 Allergy Blocker

Polyrizon Ltd., a biotech company in Israel, has announced a manufacturing agreement with Eurofins CDMO Amatsiaquitaine S.A.S, a reputable EU-based Good Manufacturing Practice (GMP) manufacturer, to ...
Business Wire

Eurofins CDMO Alphora Inc. Announces Construction of GMP Biologics Manufacturing Facility

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora Inc. announces the construction of a new GMP Biologics manufacturing facility in Mississauga, Ontario, to manufacture monoclonal Antibodies ...
Business Wire

With the Commencement of GMP Manufacturing Operations, OrganaBio’s CDMO Offers the Cell Therapy Industry Ready Access to Flexible Manufacturing Solutions and Clinical Grade ...

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...